USA - New York Stock Exchange - NYSE:EMR - US2910111044 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to EMR. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-15 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-06 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-08-07 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2025-07-16 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-14 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-09 | Barclays | Maintains | Underweight -> Underweight |
| 2025-07-02 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-01 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-07-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-13 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-06-09 | Barclays | Maintains | Underweight -> Underweight |
| 2025-06-04 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-30 | Barclays | Maintains | Underweight -> Underweight |
| 2025-05-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-05-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-08 | Barclays | Maintains | Underweight -> Underweight |
| 2025-05-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-08 | Baird | Maintains | Neutral -> Neutral |
| 2025-05-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-04-14 | Citigroup | Maintains | Buy -> Buy |
| 2025-04-10 | Barclays | Maintains | Underweight -> Underweight |
| 2025-04-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-08 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-03-26 | Barclays | Maintains | Underweight -> Underweight |
| 2025-03-17 | Citigroup | Reiterate | Buy |
34 analysts have analysed EMR and the average price target is 152.06 USD. This implies a price increase of 10.68% is expected in the next year compared to the current price of 137.39.
The consensus rating for EMERSON ELECTRIC CO (EMR) is 78.2353 / 100 . This indicates that analysts generally have a positive outlook on the stock.